Aryl hydrocarbon receptor deficiency triggers the activation of γδT17 cells to exacerbate autoimmune inflammation
Science Advances · 03.07.2026 · 12 (27)
DOI: 10.1126/sciadv.aef7793 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 03.07.2026. Verfasst von Yue He und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology of Chinese Materia Medica, School of Traditional Chinese Pharmacy, China Pharmaceutical University, 639 Long Mian Avenue, …. Hauptthemen laut MEDLINE: Receptors, Aryl Hydrocarbon, Lymphocyte Activation, Autoimmune Diseases, Inflammation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Double First Class University Project.
Abstract (Originalsprache)
Despite the well-established role of interleukin-17 (IL-17)–producing γδ T cells (γδT17 cells) in autoimmune inflammations, key factors to trigger the activation of γδT17 cells remain largely unknown. Here, we show that aryl hydrocarbon receptor (AhR) is markedly reduced upon γδT17 cell activation. AhR deficiency and pharmacological activation promotes and suppresses γδT17 cell activation, respectively. Mechanistically, AhR deficiency strengthens heat shock protein family A member 9 (HSPA9)-mediated competition with F-box and WD-40 domain protein 11(FBXW11) for binding to RBP-j-associated molecule (RAM) domain of Notch intracellular domain (NICD), which impairs FBXW11-dependent NICD ubiquitination to increase NICD occupancy at the Rorc enhancer to drive γδT17 cell activation. Consistently, AhR deficiency increases the proportion of γδT17 cells and the disease severity in psoriasis-like dermatitis mice and colitis mice, which is almost entirely reversed by pretreatment with either adeno-associated virus (AAV)-sh Hspa9 or AAV-sh Notch1 . Collectively, these findings identify AhR deficiency as a key driver of aberrant γδT17 activation, uncover a γδT17 activation mechanism via HSPA9/FBXW11-mediated suppression of NICD ubiquitination, and provide a strong mechanistic basis for AhR agonists as therapeutics in autoimmune inflammations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology of Chinese Materia Medica, School of Traditional Chinese Pharmacy, China Pharmaceutical University, 639 Long Mian Avenue, Nanjing 211198, China.
- Department of Pharmacognosy, School of Traditional Chinese Pharmacy, China Pharmaceutical University, 639 Long Mian Avenue, Nanjing 211198, China.
ORCID-Profile: Yue He, Yilei Guo, Yanrong Zhu, Haochang Lin, Yufeng Xia, Yue Dai
Förderung
- National Natural Science Foundation of China
- Double First Class University Project
Zitieren
APA
He, Y., Guo, Y., Shi, Y., Wan, X., Zhu, Y., Zhang, W., Lin, H., Wei, Z., Xia, Y., & Dai, Y. (2026). Aryl hydrocarbon receptor deficiency triggers the activation of γδT17 cells to exacerbate autoimmune inflammation. Science Advances, 12(27). https://doi.org/10.1126/sciadv.aef7793
Vancouver
He Y, Guo Y, Shi Y, Wan X, Zhu Y, Zhang W, et al. Aryl hydrocarbon receptor deficiency triggers the activation of γδT17 cells to exacerbate autoimmune inflammation. Science Advances. 2026;12(27). doi:10.1126/sciadv.aef7793
BibTeX
@article{He2026,
author = {He, Yue and Guo, Yilei and Shi, Yuxin and Wan, Xuanming and Zhu, Yanrong and Zhang, Wenjie and Lin, Haochang and Wei, Zhifeng and Xia, Yufeng and Dai, Yue},
title = {Aryl hydrocarbon receptor deficiency triggers the activation of γδT17 cells to exacerbate autoimmune inflammation},
journal = {Science Advances},
year = {2026},
volume = {12},
number = {27},
doi = {10.1126/sciadv.aef7793}
}
EUVIMED